JPMorgan Chase & Co’s AIM ImmunoTech Inc. AIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1
| Closed | -$15 | – | 6834 |
|
|
2025
Q1 | $15 | Hold |
1
| – | – | ﹤0.01% | 6286 |
|
|
2024
Q4 | $28 | Hold |
1
| – | – | ﹤0.01% | 6178 |
|
|
2024
Q3 | $37 | Hold |
1
| – | – | ﹤0.01% | 6096 |
|
|
2024
Q2 | $43 | Hold |
1
| – | – | ﹤0.01% | 6029 |
|
|
2024
Q1 | $51 | Hold |
1
| – | – | ﹤0.01% | 6023 |
|
|
2023
Q4 | $38 | Hold |
1
| – | – | ﹤0.01% | 6205 |
|
|
2023
Q3 | $27 | Buy |
+1
| New | +$27 | ﹤0.01% | 6151 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 5951 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6423 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6343 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6173 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6264 |
|
|
2022
Q1 | – | Sell |
-26
| Closed | -$2K | – | 6302 |
|
|
2021
Q4 | $2K | Hold |
26
| – | – | ﹤0.01% | 5623 |
|
|
2021
Q3 | $5K | Buy |
26
+2
| +8% | +$385 | ﹤0.01% | 5320 |
|
|
2021
Q2 | $5K | Buy |
+24
| New | +$5K | ﹤0.01% | 5310 |
|
|
2021
Q1 | – | Sell |
-31
| Closed | -$5K | – | 5585 |
|
|
2020
Q4 | $5K | Sell |
31
-143
| -82% | -$23.1K | ﹤0.01% | 4730 |
|
|
2020
Q3 | $37K | Buy |
+174
| New | +$37K | ﹤0.01% | 4369 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 5192 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 5017 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 5177 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5175 |
|